KEMRI said in a statement issued in Nairobi, the capital of Kenya, that the Phase I clinical trial of TNX-801, an investigational vaccine designed to prevent mpox will take place in Kenya, focusing on ...
Consider three topics of much public discussion: measles vaccines, raw milk and water fluoridation. All three represent fault ...
Vaccines that prevent smallpox and mpox come in two varieties. One uses a single shot of a live virus but carries the risk of ...
These vaccines are safe as they do not contain any pathogens. Moreover, these are more stable compared to live attenuated and ...
Childhood vaccinations are crucial for protecting children from deadly infections. Vaccines work by stimulating the immune ...
Research shows a single yellow fever vaccine provides lifelong immunity, with breakthrough infections being rare, supporting WHO guidelines on vaccination.
TEZSPIRE MET BOTH CO-PRIMARY ENDPOINTS IN PHASE 3 TRIAL FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
Amgen and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps (CRSwNP [nasal polyps]). The trial ...
Garfield Ekon Staff Writer The Pan American Health Organization (PAHO) is celebrating the 30th anniversary of the ...
Pregnant women and infants are at risk should they contract mpox but there are no approved vaccines for this population.
WALTHAM, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi ® ), today announced the presentation of four abstracts that ...
Third quarter 2024 U.S. BRIUMVI net revenue of $83.3 millionRaises full year 2024 U.S. BRIUMVI net revenue target to $300 - $305 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback